These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1267972)

  • 1. [Standards of good manufacturing, methods of manufacturing: an outline].
    Bertulli G; Merlini A; Zoni G
    Boll Chim Farm; 1976 Dec; 114(12):669-83. PubMed ID: 1267972
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmaceutical specialities: definitions and rules for manufacturing and marketing in Italy].
    Germani C; Montanari L; Petraroja A
    Boll Chim Farm; 1979 Mar; 118(3):135-43. PubMed ID: 475905
    [No Abstract]   [Full Text] [Related]  

  • 3. [Standards of acceptable manufacturing and inspection methods].
    Battaglino G
    Boll Chim Farm; 1984 Jun; 123(6):247-62. PubMed ID: 6497974
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmaceutical quality and good manufacturing practices (author's transl)].
    Traisnel
    J Pharm Belg; 1980; 35(3):233-7. PubMed ID: 7400928
    [No Abstract]   [Full Text] [Related]  

  • 6. Some interpretations of controversial sub-sections in the Current Good Manufacturing Practice regulations for drug products.
    Loftus BT
    J Parenter Drug Assoc; 1979; 33(6):326-32. PubMed ID: 261583
    [No Abstract]   [Full Text] [Related]  

  • 7. Anticipated revisions to the current good manufacturing practice regulations.
    Mitchell CM
    Bull Parenter Drug Assoc; 1974; 28(3):146-51. PubMed ID: 4845938
    [No Abstract]   [Full Text] [Related]  

  • 8. [Technicoscientific evolution and current direction of the standards regulating drug registration in Italy and in the European Economic Community].
    Battaglino G
    Boll Chim Farm; 1978 Jun; 117(6):313-24. PubMed ID: 743380
    [No Abstract]   [Full Text] [Related]  

  • 9. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 10. [The new norms decreed by the legislative dirrective 91-93 CCE].
    Neri M; Palazzo S
    Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 12. Manufacturing and standardizing allergen extracts in Europe.
    Larsen JN; Houghton CG; Løwenstein H; Lombardero M
    Clin Allergy Immunol; 2004; 18():433-55. PubMed ID: 15042928
    [No Abstract]   [Full Text] [Related]  

  • 13. [Official inspections of a pharmaceutical plant during the registration of new products].
    De Martiis F; Fontani F; Zanotti-Gerosa A
    Boll Chim Farm; 1982 Jul; 121(7):319-27. PubMed ID: 7150440
    [No Abstract]   [Full Text] [Related]  

  • 14. WHO expert committee on specifications for pharmaceutical preparations. Fortieth report.
    WHO Expert Committee on Specifications for Pharmaceutical Preparations
    World Health Organ Tech Rep Ser; 2006; 937():1-461, back cover. PubMed ID: 16836287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organization
    World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Guidelines on the use of medicinal plants].
    Battaglino G; Quercia V
    Boll Chim Farm; 1978 May; 117(5):251-7. PubMed ID: 743374
    [No Abstract]   [Full Text] [Related]  

  • 19. [Suggestions and recommendations for standardization of the systemic "routine" control during the production of the pharmaceutical dosage forms and their manufacturing].
    Bellentani L; Carugati E; Colombo A; Ingraffia P
    Boll Chim Farm; 1971 Mar; 110(3):131-46 contd. PubMed ID: 5561774
    [No Abstract]   [Full Text] [Related]  

  • 20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
    World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.